The U.S. has suffered a setback in its COVID-19 recovery after health authorities recommended pausing the Johnson and Johnson’s vaccine rollout. 

They made the decision after six women given the single-dose shot developed a rare, but severe blood clot. 

CGTN’s Owen Fairclough received the Johnson & Johnson vaccine less than 24 hours before the announcement was made. Here's his take.

Check out The China Report, our new weekly newsletter. Subscribe here!